Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$215M Sell
4,057,433
-901,473
-18% -$44.4M 1.85% 12
2022
Q3
$217M Buy
4,958,906
+1,933,226
+64% +$95.5M 2.11% 10
2022
Q2
$151M Buy
3,025,680
+2,640,111
+685% +$129M 1.49% 15
2022
Q1
$20M Buy
385,569
+758
+0.2% +$39.1K 0.16% 88
2021
Q4
$22.7M Buy
384,811
+124,277
+48% +$7.12M 0.18% 84
2021
Q3
$14.3M Buy
260,534
+17,766
+7% +$989K 0.12% 106
2021
Q2
$12.5M Buy
242,768
+55,142
+29% +$2.85M 0.11% 99
2021
Q1
$9.69M Buy
187,626
+124,887
+199% +$6.86M 0.1% 101
2020
Q4
$3.52M Buy
+62,739
New +$3.35M 0.04% 143

Other funds holding QGEN

Pendal Group's QGEN Position: Q4 2022 in Review

Pendal Group reduced its Qiagen (QGEN) stake by 18% in Q4 2022, selling an estimated $44.4M and leaving 4,057,433 shares worth $215M. The position accounts for 1.85% of the portfolio, ranked #12.

Pendal Group first reported a position in QGEN in Q4 2020 and has held it in 9 quarters since. The position peaked at $217M in Q3 2022. 298 funds tracked by Wall St. Rank hold QGEN as of Q4 2022.

  • Pendal Group held 4,057,433 shares of Qiagen worth $215M as of Q4 2022.
  • Pendal Group sold 901,473 Qiagen shares in Q4 2022, an estimated $44.4M.
  • Qiagen made up 1.85% of Pendal Group's portfolio in Q4 2022, its #12 holding.
  • Pendal Group first reported a position in Qiagen in Q4 2020 and has held it in 9 quarters since.
  • Pendal Group's Qiagen position peaked at $217M in Q3 2022.
  • 298 funds tracked by Wall St. Rank held Qiagen as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.